Invention Grant
- Patent Title: Chondrosulphatase and use thereof
-
Application No.: US17601080Application Date: 2019-09-18
-
Publication No.: US11667901B2Publication Date: 2023-06-06
- Inventor: Haoning Zhang , Song Chen , Chuangen Tang , Jing Wang
- Applicant: NANJING HANXIN PHARMACEUTICAL INC
- Applicant Address: CN Jiangsu
- Assignee: NANJING HANXIN PHARMACEUTICAL INC
- Current Assignee: NANJING HANXIN PHARMACEUTICAL INC
- Current Assignee Address: CN Jiangsu
- Agency: JCIP Global Inc.
- Priority: CN 1910264385.5 2019.04.03
- International Application: PCT/CN2019/106448 2019.09.18
- International Announcement: WO2020/199521A 2020.10.08
- Date entered country: 2021-10-03
- Main IPC: C12N9/16
- IPC: C12N9/16

Abstract:
Provided are chondrosulfatase and a use thereof, belonging to the technical field of biological engineering. Chondrosulfatase is screened and identified from the natural world, the maximum similarity between its amino acid sequence and that of the chondrosulfatase reported by NCBI being 85%; then the expression in Escherichia coli and Bacillus subtilis is optimized, achieving the high-efficiency biosynthesis of chondrosulfatase having high enzymatic activity, the maximum enzyme activity being 11976.5 U/L; furthermore, the entire process and post-processing are simpler. The invention has potentially broad value in application in the preparation of products containing low molecular-weight chondroitin sulfate in the fields of medicine, cosmetics, and biology, lays the foundation for efficient fermentation of a microbial system to produce a chondrosulfatase having high enzyme activity, and is suitable for industrialized production applications.
Public/Granted literature
- US20220259577A1 CHONDROSULPHATASE AND USE THEREOF Public/Granted day:2022-08-18
Information query